Advertisement

Topics

Standardizing on Veeva Vault Enhances Regeneron’s Clinical and Regulatory Operations Processes

07:03 EDT 19 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Leading biotechnology company using Veeva Vault Submissions and Veeva Vault eTMF to support the development of new medicines DIA 2017 Annual Meeting — Veeva Systems (NYSE: VEEV) today announced that Regeneron Pharmaceutica...

Other Sources for this Article

Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Veeva Systems
Lisa Barbadora, 610-420-3413
pr@veeva.com

NEXT ARTICLE

More From BioPortfolio on "Standardizing on Veeva Vault Enhances Regeneron’s Clinical and Regulatory Operations Processes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...